UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

Clinical pharmacokinetics, 2010-10, Vol.49 (10), p.633-659

2010

Volltextzugriff (PDF)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1098-1110

2021

Volltextzugriff (PDF)

A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.135-145

2024

Volltextzugriff (PDF)

Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype

Journal of affective disorders, 2024-02, Vol.346, p.64-74

2024

Volltextzugriff (PDF)

Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease

British journal of clinical pharmacology, 2022-01, Vol.88 (1), p.323-335

2022

Volltextzugriff (PDF)

Methods and software tools for design evaluation in population pharmacokinetics–pharmacodynamics studies

British journal of clinical pharmacology, 2015-01, Vol.79 (1), p.6-17

2015

Volltextzugriff (PDF)

Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria

Antimicrobial agents and chemotherapy, 2020-06, Vol.64 (7)

2020

Volltextzugriff (PDF)

Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model

Pharmacotherapy, 2023-02, Vol.43 (2), p.145-157

2023

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects

British journal of clinical pharmacology, 2013-01, Vol.75 (1), p.197-207

2013

Volltextzugriff (PDF)

Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients

Journal of pharmaceutical sciences, 2014-01, Vol.103 (1), p.328-336

2014

Volltextzugriff (PDF)

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer

Cancer chemotherapy and pharmacology, 2012-10, Vol.70 (4), p.591-601

2012

Volltextzugriff (PDF)

Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain

Clinical pharmacokinetics, 2010-10, Vol.49 (10), p.671-682

2010

Volltextzugriff (PDF)

Understanding the time course of pharmacological effect: a PKPD approach

British journal of clinical pharmacology, 2011-06, Vol.71 (6), p.815-823

2011

Volltextzugriff (PDF)

Pharmacokinetic–pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: The use of PANSS total score and clinical utility

Schizophrenia research, 2013-05, Vol.146 (1), p.144-152

2013

Volltextzugriff (PDF)

Population Pharmacokinetics of High-dose Methotrexate After Intravenous Administration in Chinese Osteosarcoma Patients from a Single Institution

Chinese medical journal, 2015-01, Vol.128 (1), p.111-118

2015

Volltextzugriff (PDF)

Predicting Passive and Active Tissue:Plasma Partition Coefficients: Interindividual and Interspecies Variability

Journal of pharmaceutical sciences, 2014-07, Vol.103 (7), p.2189-2198

2014

Volltextzugriff (PDF)

Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase

Journal of clinical pharmacology, 2016-11, Vol.56 (11), p.1433-1447

2016

Volltextzugriff (PDF)

Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (6), p.e0243021-e0243021

2022

Volltextzugriff (PDF)

Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software

Clinical pharmacokinetics, 2012-08, Vol.51 (8), p.515-525

2012

Volltextzugriff (PDF)

Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia

Journal of pharmaceutical sciences, 2024-09

2024

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram

International journal of antimicrobial agents, 2022-06, Vol.59 (6), p.106600-106600, Article 106600

2022

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis and Dosing Optimization of Colistin Sulfate in Lung Transplant Recipients with Pneumonia: A Prospective Study

International journal of antimicrobial agents, 2024-09, p.107346, Article 107346

2024

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia

Antibiotics (Basel), 2020-03, Vol.9 (3), p.113

2020

Volltextzugriff (PDF)

Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach

Journal of clinical pharmacology, 2006-11, Vol.46 (11), p.1370-1378

2006

Volltextzugriff (PDF)

Nonparametric Methods in Population Pharmacokinetics

Journal of clinical pharmacology, 2022-02, Vol.62 (2), p.142-157

2022

Volltextzugriff (PDF)

1 – 25 von 7.311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.896)
Mit Volltextzugriff
(5.871)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia

A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status

Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype

Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease

Methods and software tools for design evaluation in population pharmacokinetics–pharmacodynamics studies

Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria

Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model

Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects

Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer

Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain

Understanding the time course of pharmacological effect: a PKPD approach

Pharmacokinetic–pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: The use of PANSS total score and clinical utility

Population Pharmacokinetics of High-dose Methotrexate After Intravenous Administration in Chinese Osteosarcoma Patients from a Single Institution

Predicting Passive and Active Tissue:Plasma Partition Coefficients: Interindividual and Interspecies Variability

Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase

Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections

Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software

Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia

Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram

Population Pharmacokinetic Analysis and Dosing Optimization of Colistin Sulfate in Lung Transplant Recipients with Pneumonia: A Prospective Study

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia

Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach

Nonparametric Methods in Population Pharmacokinetics

Suchergebnisse filtern